Caffeine treatment groups | |||
---|---|---|---|
Placebo (N = 15) | 200 mg (N = 15) | 400 mg (N = 15) | |
Caffeine dosage (mg/kg) | 0.00 ± 0.00 | 2.64 ± 0.091 | 5.51 ± 0.281 |
Systolic blood pressure (mmHg) | |||
Baseline | 112.76 ± 2.06 | 116.76 ± 2.06 | 116.45 ± 2.06 |
Task performance | 113.54 ± 2.44 | 116.26 ± 2.44 | 121.02 ± 2.44 |
Recovery | 114.93 ± 2.202,3 | 120.35 ± 2.202,3 | 122.20 ± 2.202,3 |
Diastolic blood pressure (mmHg) | |||
Baseline | 65.16 ± 1.67 | 65.33 ± 1.67 | 65.43 ± 1.67 |
Task performance | 65.55 ± 1.91 | 67.98 ± 1.91 | 68.99 ± 1.91 |
Recovery | 70.73 ± 1.742,4 | 70.73 ± 1.742,4 | 70.93 ± 1.742,4 |
Heart rate (BPM) | |||
Baseline | 64.84 ± 2.29 | 65.49 ± 2.29 | 67.25 ± 2.29 |
Task performance | 66.52 ± 2.24 | 65.19 ± 2.24 | 68.74 ± 2.24 |
Recovery | 64.13 ± 2.002,5 | 61.73 ± 2.002,5 | 63.56 ± 2.002,5 |